Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Non Fusion Spinal Devices Market Outlook

The non fusion spinal devices market is expected to be valued at US$ 4.37 billion in 2023. The market is projected to rise at a CAGR of 4.8% from 2023 to 2033, to attain a market value of US$ 6.99 billion by 2033.

The global demand for non fusion spinal devices is driven by:

  • Rising preference for minimally invasive surgery treatments
  • Expanding the base of an aging population
  • Technological improvements
  • Rising obesity rates
  • Intense market competition

The non fusion spinal devices market is witnessing an upsurge because of the rising prevalence of spinal disorders, such as spinal stenosis and degenerative disc disease.

Spinal implants are used to provide stability and invigorate the spine of patients, in addition, to treating disproportion of the spine. These devices are broadly segmented as fusion and non-fusion spinal devices. Integration of non-fusion technologies into spinal surgery has improved outcomes by providing patients with at least some movements and flexibility in the spine.

The demand for non-fusion spinal devices mainly originates from patients who are suffering from the problem of gradual disc damage. Degenerative disc disease often results in disc herniation, and chronic back or neck pain.

As per WHO, back pain impacts all people, irrespective of their age, from children to the elderly, and is a recurrent factor behind medical consultations. It is hard to guesstimate the incidence of back pain, as its occurrence is already quite high by the time a person reaches adulthood, and the symptoms are liable to recur over time. In industrialized countries, the lifetime pervasiveness of non-specific (common) back pain is projected to be 60% to 70%.

Aggressive operations, along with technological advancement, are pushing the adoption of non-fusion spinal devices. Furthermore, issues such as heart attack and obesity that are being brought upon by the swelling geriatric population and lifestyle problems, are boosting the global demand for non-fusion spinal devices.

Increasing cases of spinal illnesses, such as degenerative disc disease, as well as an aging population, are propelling the global demand further for non-fusion spinal devices forward, particularly in the United States and Europe.

Report Attribute Details
Estimated Base Year Value (2023) US$ 4.37 billion
Projected Growth Rate (2023 to 2033) 4.8% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Significant Factors Responsible for the Expansion of Non Fusion Spinal Devices Market

The non-fusion spinal devices market is maneuvered by the ongoing technological advances and release of the latest iterations of treatment products. Many companies leading in spine innovation, to improve patients’ quality of life, are delivering comprehensive biologics, cervical, and thoracolumbar solutions, navigation, and robotics technologies. The key participants are also offering training as well as clinical support to surgeons.

By providing innovative spine products, leading companies are enabling outcome-centered and clinically-proven designs, and anatomically-comprehensive treatments ranging from sacrum to occipital-cervical-thoracic. These devices also enable the possibility of diverse treatment philosophies, such as minimally invasive procedures. Further, technological advances such as 3D printed titanium and VerteBRIDGE® in the spine products have boosted the relevance of the wide patient population and spine pathologies like adolescent deformity, aging degenerative discs, and active motion preservation.

With rapid technological advancement and wide acceptance of non-fusion spinal technologies and disc diagnostic devices among patients with back pain problems, the global non-fusion spinal devices market is expected to hold a 4.8% CAGR in the forecast period.

(2017 to 2022) Demand Outlook for Non Fusion Spinal Devices Market Compared to Forecast Period (2023 to 2033)

The market is estimated to attain a market value of US$ 4.37 billion by 2023. Over the historical period, the non-fusion spinal devices industry has been positively influenced by several factors, such as the surging adoption of minimally invasive spinal surgeries, new technological advances in the spinal surgery sector, the rising obese population, and degenerative spinal conditions.

By 2033, the market is estimated to attain US$ 6.99 billion, expanding at a CAGR of 4.8% in the forecast period. Future Market Insights examines upcoming trends against the given time duration:

Year Expected Valuation
2025 US$ 4.80 billion
2028 US$ 5.52 billion
2032 US$ 6.66 billion
  • Short Term (2023 to 2026): Escalating the prevalence of obesity is supporting the demand for non-fusion spinal devices. As obese people have a high Body Mass Index (BMI), these people are more susceptible to spine-associated ailments and back pain.
  • Medium Term (2026 to 2029): Production of inventive products by key players is anticipated to result in the continuous growth of the market. The development of advanced spinal surgery devices to mitigate pain sans the requirement for invasive surgery is expected to push market development.
  • Long Term (2029 to 2033): The well-designed studies conducted by extensive medical centers to find out the extent to which stenosis, scoliosis, and spondylolisthesis can be effectively treated with non-fusion devices are expected to impel the market growth.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative Analysis of Adjacent Markets

Non Fusion Spinal Devices Market:

Differentiating Aspects Non Fusion Spinal Devices Market
CAGR (Forecast Period) 4.8%
Market Valuation in 2023 US$ 4.37 billion
Projected Market Value by 2033 US$ 6.99 billion
Growth Factors Growing geriatric population.
Trends Increasing preference for minimally invasive surgeries.
Opportunities Expanding healthcare infrastructure.

Spinal Devices Market:

Differentiating Aspects Spinal Devices Market
CAGR (Forecast Period) 5.3%
Market Valuation in 2023 US$ 13.79 billion
Projected Market Value by 2033 US$ 23.12 billion
Growth Factors Increasing cases of spinal cord injuries (SCI).
Trends Surging elderly population and the number of obese people who frequently develop symptoms linked with the spinal disorder.
Opportunities Rising government expenditure for further technological evolution of products.

General Surgery Devices Market:

Differentiating Aspects General Surgery Devices Market
CAGR (Forecast Period) 8.2%
Market Valuation in 2023 US$ 17.27 billion
Projected Market Value by 2033 US$ 37.98 billion
Growth Factors The high incidence rate of gastrointestinal diseases, osteoporosis, and cardiac diseases.
Trends Rising application of robotics in general surgeries.
Opportunities Accelerating acceptance of computer and robotic-assisted surgery.

Category-wise Insights

Dynamic Stabilization Devices to Lead the Product Segment

The dynamic stabilization devices segment is projected to account for a significant market percentage over the forecast period. These devices comprise pedicle screw-based systems, facet replacement products, and interspinous process spacers. The segment growth can be ascribed to the utilization of rigid spinal implants due to their fusion technologies. Additionally, the ongoing transformation in therapeutic procedures owing to technological innovations, such as the adoption of BioFlex systems and improvements in biochemical, is projected to facilitate segment development.

The adoption of dynamic stabilization devices is projected to be fueled by the increasing cases of lumbar disc herniation, which results in the lower back as well as radicular leg pain. These devices assist in the treatment of lumbar degenerative diseases.

Hospitals Segment to Generate Substantial Market Revenue

The hospital segment is expected to significantly contribute to the market growth. The growth of this segment can be credited to the easy access to advanced healthcare infrastructure in the developed regions, in addition to the growing demand for high-quality healthcare services. The availability of skilled surgeons and numerous healthcare providers at hospitals ensures intensive care throughout and post the surgery, disparate from other surgical centers. Thus, boosting the expansion of this segment.

The orthopedic center segment is anticipated to expand at a significant rate in the coming years. The robust growth of this segment can be attributed to the emerging field of spine surgery that includes orthopedic surgeons specialized in spine surgeries.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Players Exerting Intensely to Rise above the Market Rivalry

The non fusion spinal devices market players are vigorously responding to the increasing demand for non-fusion spinal devices by developing new, more advanced products. Additionally, the market participants are employing various tactics, such as acquisitions, mergers, product upgradation, etc., to strengthen their hold over the market. The high demand for these devices is pushing key players to make proactive decisions to rise above the existing market rivalry.

Latest developments:

  • In November 2022, Spinal Stabilization Technologies Ltd announced that it has commenced with the LOPAIN2 clinical trial to check the effectiveness of PerQdisc Nucleus Replacement Device (NRD). The trial is estimated to take place in South America, with 72 patients enrolled for the same.
  • In August 2021, Orthofix US LLC officially declared the first patient implant in the M6-C Artificial Cervical Disc 2-Level Investigation Device Exemption (IDE) Study. The FDA-approved M6-C artificial cervical disc in 2019 for single-level implantation from C3 to C7 is a substitute for cervical fusion.
  • In April 2021, NuVasive Inc got the approval of 510k from the United States FDA for the usage of Simplify Disc, a two-level cervical total disc replacement.

Prominent Companies Active in the Market are as follows

  • Zimmer Biomet
  • Medtronic
  • Medical Device Business Services, Inc.
  • Stryker
  • Others

Scope of Non Fusion Spinal Devices Market Report

Attributes Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million/ billion for Value
By Product
  • Artificial Disc Replacement Device
  • Partial Disc (Nucleus) Replacement Device
  • Dynamic Stabilization Devices
  • Total Facet Replacement Devices
  • Annulus Repair Device
  • Others
By End User
  • Hospitals
  • Orthopedic Centers
  • Others
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa
Key Players
  • Zimmer Biomet
  • Medtronic
  • Medical Device Business Services, Inc.
  • Stryker
  • Others

Key Market Segmentation for Non Fusion Spinal Devices Market

By Product:

  • Artificial Disc Replacement Device
  • Partial Disc (Nucleus) Replacement Device
  • Dynamic Stabilization Devices
  • Total Facet Replacement Devices
  • Annulus Repair Device
  • Others

By End User:

  • Hospitals
  • Orthopedic Centers
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • The Middle East and Africa
  • Europe

Frequently Asked Questions

What is the Non Fusion Spinal Devices Market CAGR for 2033?

The non fusion spinal devices market CAGR for 2033 is 4.8%.

How Big Will the Non Fusion Spinal Devices Market by 2033?

The market is estimated to reach US$ 6.99 billion by 2033.

How Key Players are Developing the Non Fusion Spinal Devices Market?

Key players in the non fusion spinal devices market are developing it by introducing innovative products.

What is the Current Non Fusion Spinal Devices Market Valuation?

The market is estimated to secure a valuation of US$ 4.37 billion in 2023.

Who are the Three Key Players in the Non Fusion Spinal Devices Market?

Medtronic, Zimmer Biomet, and NuVasive are the key non fusion spinal devices market players.

Table of Content

1. Executive Summary | Non Fusion Spinal Devices Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Artificial Disc Replacement Device

        5.3.2. Partial Disc (Nucleus) Replacement Device

        5.3.3. Dynamic Stabilization Devices

        5.3.4. Annulus Repair Devices

        5.3.5. Total Facet Replacement Device

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Orthopaedic Centres

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Singapore

            11.2.1.5. Thailand

            11.2.1.6. Indonesia

            11.2.1.7. Australia

            11.2.1.8. New Zealand

            11.2.1.9. Rest of Asia Pacific

        11.2.2. By Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By End User

    11.4. Key Takeaways

12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By End User

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. USA

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2022

            13.1.2.1. By Type

            13.1.2.2. By End User

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2022

            13.2.2.1. By Type

            13.2.2.2. By End User

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2022

            13.3.2.1. By Type

            13.3.2.2. By End User

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2022

            13.4.2.1. By Type

            13.4.2.2. By End User

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2022

            13.5.2.1. By Type

            13.5.2.2. By End User

    13.6. United Kingdom

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2022

            13.6.2.1. By Type

            13.6.2.2. By End User

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2022

            13.7.2.1. By Type

            13.7.2.2. By End User

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2022

            13.8.2.1. By Type

            13.8.2.2. By End User

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2022

            13.9.2.1. By Type

            13.9.2.2. By End User

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2022

            13.10.2.1. By Type

            13.10.2.2. By End User

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2022

            13.11.2.1. By Type

            13.11.2.2. By End User

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2022

            13.12.2.1. By Type

            13.12.2.2. By End User

    13.13. Singapore

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2022

            13.13.2.1. By Type

            13.13.2.2. By End User

    13.14. Thailand

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2022

            13.14.2.1. By Type

            13.14.2.2. By End User

    13.15. Indonesia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2022

            13.15.2.1. By Type

            13.15.2.2. By End User

    13.16. Australia

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2022

            13.16.2.1. By Type

            13.16.2.2. By End User

    13.17. New Zealand

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2022

            13.17.2.1. By Type

            13.17.2.2. By End User

    13.18. GCC Countries

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2022

            13.18.2.1. By Type

            13.18.2.2. By End User

    13.19. South Africa

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2022

            13.19.2.1. By Type

            13.19.2.2. By End User

    13.20. Israel

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2022

            13.20.2.1. By Type

            13.20.2.2. By End User

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Type

        14.3.3. By End User

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. B Braun Melsungen

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

                15.1.1.5.2. Product Strategy

                15.1.1.5.3. Channel Strategy

        15.1.2. Centinel Spine LLC

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

                15.1.2.5.2. Product Strategy

                15.1.2.5.3. Channel Strategy

        15.1.3. Johnson & Johnson

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

                15.1.3.5.2. Product Strategy

                15.1.3.5.3. Channel Strategy

        15.1.4. Medtronic PLC

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

                15.1.4.5.2. Product Strategy

                15.1.4.5.3. Channel Strategy

        15.1.5. Pioneer Surgical Technologies

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

                15.1.5.5.2. Product Strategy

                15.1.5.5.3. Channel Strategy

        15.1.6. Stryker Corporation

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

                15.1.6.5.2. Product Strategy

                15.1.6.5.3. Channel Strategy

        15.1.7. Zimmer Holdings Inc.

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

                15.1.7.5.2. Product Strategy

                15.1.7.5.3. Channel Strategy

        15.1.8. RTI Surgical Holdings Inc.

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

                15.1.8.5.2. Product Strategy

                15.1.8.5.3. Channel Strategy

        15.1.9. NuVasive Inc.

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

                15.1.9.5.2. Product Strategy

                15.1.9.5.3. Channel Strategy

        15.1.10. Paradigm Spine

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

                15.1.10.5.2. Product Strategy

                15.1.10.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Recommendations

Healthcare

Spinal Fusion Market

Published : September 2023

Healthcare

Spinal Devices Market

Published : December 2022

Explore Healthcare Insights

View Reports

Non Fusion Spinal Devices Market